Instil Bio, Inc. (TIL) Daily Stock Prediction

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

150

Address:

Instil Bio, Inc. 3963 Maple Avenue Suite 350 Dallas TX 75219 United States

Website:

Home

Phone:

240-676-3715